At follow-up , 12 of 69 ( 17 % ) women allocated to electrocautery , and 13 of 69 ( 19 % ) women allocated to gonadotropins had evidence for metabolic or cardiovascular disease ( relative risk 0.90 ; 95 % confidence interval 0.39-2 .1 ) .